Michael Byrnes
2016 - Ocera Therapeutics
In 2016, Michael Byrnes earned a total compensation of $910.7K as Chief Financial Officer at Ocera Therapeutics, a 52% increase compared to previous year.
Compensation breakdown
| Bonus | $14,625 |
|---|---|
| Non-Equity Incentive Plan | $110,500 |
| Option Awards | $452,373 |
| Salary | $325,000 |
| Other | $8,190 |
| Total | $910,688 |
Byrnes received $452.4K in option awards, accounting for 50% of the total pay in 2016.
Byrnes also received $14.6K in bonus, $110.5K in non-equity incentive plan, $325K in salary and $8.2K in other compensation.
Rankings
In 2016, Michael Byrnes' compensation ranked 8,683rd out of 14,075 executives tracked by ExecPay. In other words, Byrnes earned more than 38.3% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 8,683 out of 14,075 | 38th |
Division Manufacturing | 3,356 out of 5,489 | 39th |
Major group Chemicals And Allied Products | 1,141 out of 1,895 | 40th |
Industry group Drugs | 896 out of 1,538 | 42nd |
Industry Pharmaceutical Preparations | 713 out of 1,176 | 39th |
Source: SEC filing on April 25, 2017.
Byrnes' colleagues
We found three more compensation records of executives who worked with Michael Byrnes at Ocera Therapeutics in 2016.